Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 3Phase NA 1

Status

Active not recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3

Conditions

Peritoneal Neoplasms 1Ovarian Neoplasms 1Ovarian Epithelial Cancer Recurrent 1Krukenberg Tumor 1

Interventions

Carboplatin 129pembrolizumab 124Cisplatin 114Paclitaxel 102Gemcitabine 85Specimen Handling 80Magnetic Resonance Spectroscopy 80Docetaxel 70Dexamethasone 59Cyclophosphamide 59Pemetrexed 55Bevacizumab 54durvalumab 53Doxorubicin 52Radiotherapy 49Capecitabine 49Radiation 47Oxaliplatin 47Fluorouracil 47Rituximab 42Leucovorin 42Vincristine 41Lenalidomide 40Etoposide 38Letrozole 36atezolizumab 35Nivolumab 35Prednisone 31Bortezomib 31130-nm albumin-bound paclitaxel 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Hyperthermic Intraperitoneal Chemotherapy × 90 days × Clear all
NCT01376752 2026-05-20

CHIPOR

UNICANCER

Phase 3 Active not recruiting
415 enrolled
Gynecologic

Ovarian Epithelial Cancer Recurrent

NCT01226394 2026-04-06

ProphyloCHIP

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed
150 enrolled
Gynecologic

Krukenberg Tumor, Peritoneal Neoplasms

NCT03842982 2026-03-16

CHIPPI

Centre Oscar Lambret

Phase 3 Active not recruiting
362 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡